TY - JOUR
T1 - Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis
AU - Macari, Francoise
AU - Landau, Marina
AU - Cousin, Pascal
AU - Mevorah, Barukh
AU - Brenner, Sarah
AU - Panizzon, Renato
AU - Schorderet, Daniel F.
AU - Hohl, Daniel
AU - Huber, Marcel
N1 - Funding Information:
This project was supported by Swiss National Science Foundation grant 31-55849.98 (to D.H. and M.H.) and a grant by the Faculty of Medcine, University of Lausanne (to D.H. and D.S.). We thank F. Peneveyre for technical help, P. Meda for reviewing the manuscript before submission, and J.A. Häfliger for helpful discussions.
PY - 2000
Y1 - 2000
N2 - Erythrokeratodermia variabilis (EKV) is an autosomal dominant keratinization disorder characterized by migratory erythematous lesions and fixed keratotic plaques. All families with EKV show mapping to chromosome 1p34-p35, and mutations in the gene for connexin 31 (Cx31) have been reported in some but not all families. We studied eight affected and three healthy subjects in an Israeli family, of Kurdish origin, with EKV. After having mapped the disorder to chromosome 1p34-p35, we found no mutations in the genes for Cx31, Cx31.1, and Cx37. Further investigation revealed a heterozygous T→C transition leading to the missense mutation (F137L) in the human gene for Cx30.3 that colocalizes on chromosome 1p34-p35. This nucleotide change cosegregated with the disease and was not found in 200 alleles from normal individuals. This mutation concerns a highly conserved phenylalanine, in the third transmembrane region of the Cx30.3 molecule, known to be implicated in the wall formation of the gap-junction pore. Our results show that mutations in the gene for Cx30.3 can be causally involved in EKV and point to genetic heterogeneity of this disorder. Furthermore, we suggest that our family presents a new type of EKV because of the hitherto unreported association with erythema gyratum repens.
AB - Erythrokeratodermia variabilis (EKV) is an autosomal dominant keratinization disorder characterized by migratory erythematous lesions and fixed keratotic plaques. All families with EKV show mapping to chromosome 1p34-p35, and mutations in the gene for connexin 31 (Cx31) have been reported in some but not all families. We studied eight affected and three healthy subjects in an Israeli family, of Kurdish origin, with EKV. After having mapped the disorder to chromosome 1p34-p35, we found no mutations in the genes for Cx31, Cx31.1, and Cx37. Further investigation revealed a heterozygous T→C transition leading to the missense mutation (F137L) in the human gene for Cx30.3 that colocalizes on chromosome 1p34-p35. This nucleotide change cosegregated with the disease and was not found in 200 alleles from normal individuals. This mutation concerns a highly conserved phenylalanine, in the third transmembrane region of the Cx30.3 molecule, known to be implicated in the wall formation of the gap-junction pore. Our results show that mutations in the gene for Cx30.3 can be causally involved in EKV and point to genetic heterogeneity of this disorder. Furthermore, we suggest that our family presents a new type of EKV because of the hitherto unreported association with erythema gyratum repens.
UR - http://www.scopus.com/inward/record.url?scp=0033760288&partnerID=8YFLogxK
U2 - 10.1016/S0002-9297(07)62957-7
DO - 10.1016/S0002-9297(07)62957-7
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0033760288
SN - 0002-9297
VL - 67
SP - 1296
EP - 1301
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 5
ER -